Skills Ontario and Indigenous owned ORIGIN bring skilled trades to life in “Trade Up! Be Proud, Be Skilled” Virtual Reality Careers Campaign
May 17, 2021 09:02 ET | ORIGIN
ONTARIO, May 17, 2021 (GLOBE NEWSWIRE) -- Skills Ontario and Indigenous owned VR Production company, Origin, have teamed up to develop 25 virtual reality “career tour” experiences as part of Skills...
unnamed.jpg
Introducing Origin - Physical Therapy Designed for Women and Mothers
April 30, 2020 12:03 ET | Origin
LOS ANGELES, April 30, 2020 (GLOBE NEWSWIRE) -- Today, Origin - physical therapy designed for women and mothers - launched virtual care to support those at home during the COVID-19 pandemic. Women...
OriginLogo.jpg
Origin files patent application to protect its proposed treatment for viral and bacterial respiratory infections
March 24, 2020 07:00 ET | Origin
PRINCETON, N.J., March 24, 2020 (GLOBE NEWSWIRE) -- Origin, Inc., a Phase III clinical-stage biotechnology company, today announced that it has filed a provisional U.S. patent application to enhance...
OriginLogo.jpg
Origin applies to China regulatory agency for clinical pathway classification
October 28, 2019 08:00 ET | Origin
PRINCETON, New Jersey, Oct. 28, 2019 (GLOBE NEWSWIRE) -- Origin, Inc., a Phase III clinical-stage biotechnology company, today announced that it had applied to NMPA (formerly CFDA) for...
OriginLogo.jpg
Origin Successfully Achieves Phase IIb GENESIS Trial Objectives Ahead of Schedule and Announces Early Termination of Study
April 18, 2018 08:30 ET | Origin
PRINCETON, N.J., April 18, 2018 (GLOBE NEWSWIRE) -- Origin, Inc., a Phase IIb clinical-stage biotechnology company, today announced that the US Food and Drug Administration has approved its request...
OriginLogo.jpg
Origin™ Announces Positive Interim Results from Phase IIb Dose-Ranging Study for Diabetic Foot Ulcers
October 26, 2017 08:30 ET | Origin
Interim results demonstrate strong evidence of healing and favorable safety profileHighest-performing arm (4X per week, 12 minutes):•  95% mean wound-size reduction in 12 weeks•  71% of wounds...
OriginLogo.jpg
Origin™ Announces First 50 Patients Randomized, and Full Site Activation in Phase IIb Dose-Ranging Study for Diabetic Foot Ulcers
June 01, 2017 08:30 ET | Origin
PRINCETON, N.J., June 01, 2017 (GLOBE NEWSWIRE) -- Origin, Inc. (formerly Advanced Plasma Therapies, Inc), a Princeton, NJ based clinical-stage wound care company focused on treatment of Diabetic...